Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nortriptyline versus melatonin for painful diabetic polyneuropathy
IRCT20191030045277N2Phase 3Completed
- Sponsor
- Babol University of Medical Sciences
- Start
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of nortriptyline and melatonin in diabetic polyneuropathy (DPN) (2 arms), sponsored by Babol University of Medical Sciences. Primary endpoint: Neuropathic pain. Started Dec 2019; status: completed.
02
Drugs
nortriptylinemelatonin
03
Conditions
diabetic polyneuropathy (DPN)
Beyond the preview
Go deeper on IRCT20191030045277N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20191030045277N2.